<html>
<head>
	<META HTTP-EQUIV="Pragma" CONTENT="no-cache">
	<META HTTP-EQUIV="Cache-Control" CONTENT="no-store">
	<title> Teva Implementing a Worldwide Employee Stock Option Plan for Key Employees </title>
<!-- Hiding from old browsers -->
<SCRIPT LANGUAGE=JavaScript>
   function userButton(btnStr)
   {
      document.forms[0].theButton.value = btnStr;
      document.forms[0].submit();
   }
<!-- End Hiding from old browsers -->
</SCRIPT>
</head>

<body BGCOLOR="#FFFFFF">
<table border="0" cellspacing="0" cellpadding="0" width="468">
<TR><TD width="468">
<FONT FACE="verdana, arial, helvetica, san-serif" SIZE="+1">

<!-- Begin DoubleClick ad head --><NOLAYER><IFRAME SRC="http://ad.doubleclick.net/adi/np.newspage.com/Generic+Drugs;depid=536;!category=np_comp;u=b0828134_602;sz=468x60;ord=967546722488?" name="banner" frameborder=0 marginheight=0 marginwidth=0 width=468 height=80 scrolling=no><A HREF="http://ad.doubleclick.net/jump/np.newspage.com/Generic+Drugs;depid=536;!category=np_comp;u=b0828134_602;sz=468x60;ord=967546722488?" target="_top"><IMG BORDER="0" SRC="http://ad.doubleclick.net/ad/np.newspage.com/Generic+Drugs;depid=536;!category=np_comp;u=b0828134_602;sz=468x60;ord=967546722488?"><BR>Click Here!</A></IFRAME></NOLAYER><ILAYER ID=banner VISIBILITY=HIDE HEIGHT=80 WIDTH=468></ILAYER><!-- End DoubleClick ad head -->

<br>
<br>
<B>Teva Implementing a Worldwide Employee Stock Option Plan for Key Employees</B></FONT>
</td></tr>
<!--blue line -->
<TR>
<TD BGCOLOR="#003366"><IMG SRC="/images/util/dotclear.gif" HEIGHT="4" WIDTH="1"></TD>
</TR> 

<TR><TD width="468"> 
	<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" width="468">
    <TR>
	<!-- story area -->
    <TD VALIGN="top" width="468">
      <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" width="328">
        <TR><TD width="328"><IMG SRC="/images/util/dotclear.gif" WIDTH="1" HEIGHT="5"></TD></TR>
		<TR><TD width="328"><FONT FACE= "verdana, arial, helvetica, san-serif">
		<FONT SIZE="-1"> <B> August 29, 2000
 </B><br><br><input type="Hidden" NAME="theButton"><A HREF=JavaScript:userButton("Email_frames")><img src="/images/buttons/email_story_to_a_friend_b.gif" border="0"></A>&nbsp;<A HREF=JavaScript:userButton("Fax_frames")><img src="/images/buttons/fax_story_to_a_friend_b.gif" border="0"></A><BR> <HR SIZE="1" NOSHADE><P>
		
<!-- begin full-text -->
<EM>JERUSALEM, Israel--(BUSINESS WIRE)--August 28, 2000 via NewsEdge Corporation </EM> - <P>
Teva
Pharmaceutical Industries Ltd, (NASDAQ:TEVA) announced today that its
Board of Directors has approved a stock option program under which an
aggregate of up to 6.25 million Teva ordinary shares will be made
available for stock option grants over the next 5 years to key
employees of Teva on a worldwide basis.
</P>
<P>
An initial group of stock options covering a total of 800,000
shares (out of the first portion of 1.25 million shares) were granted
to 240 employees in Israel by the Board of Directors in its meeting of
August 21st, 2000. These options have the following terms: they expire
after 5 years; The options will be subject to a vesting schedule such
that 25% of the options will be exercisable at any time after 24
months from the date of issuance, another 25% at the end of 36 months
and the balance of 50% will be vested on the 48 month anniversary of
the date of issuance; The exercise price will be $63.56 per share. The
options themselves are not tradable but the shares underlying the
options will be listed on the Tel-Aviv Stock Exchange.
</P>
<P>
Eli Hurvitz, President and Chief Executive Officer of Teva stated:
&quot;The purpose of the plan is to enable our employees to share in the
company's success and recognize their contribution to that success.
The plan is a means of incentivizing our employees by linking their
future to that of the company thus recognizing them as one of the
company's most important assets&quot;.
</P>
<P>
The plan is subject to the consent of the Tel Aviv Stock Exchange
to list the underlying shares and to the approval of the Israeli tax
authorities.
</P>
<P>
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is
among the top 50 pharmaceutical companies and among the largest
generic pharmaceutical companies in the world. Over 80% of its sales
are outside Israel, mainly in North America and Europe. The Company
develops, manufactures, and markets generic and branded human
pharmaceuticals and active pharmaceutical ingredients.
</P>
<P>
Safe Harbor Statement: This report contains forward-looking
statements, which express the beliefs and expectations of management.
Such statements are based on current expectations and involve a number
of known and unknown risks and uncertainties that could cause the
Company's future results, performance or achievements to differ
significantly from the results, performance or achievements expressed
or implied by such forward looking statements. Important factors that
could cause or contribute to such differences include the impact of
pharmaceutical industry regulation, the difficulty of predicting FDA
and other regulatory authority approvals, the regulatory environment
and changes in the health policies and structure of various countries,
acceptance and demand for new pharmaceutical products and new
therapies, the impact of competitive products and pricing, the
availability and pricing of ingredients used in the manufacture of
pharmaceutical products, uncertainties regarding market acceptance of
innovative products newly launched, currently being sold or in
development , the impact of restructuring of clients , reliance on
strategic alliances , fluctuations in currency, exchange and interest
rates, operating results , the impact of the year 2000 issue and other
factors that are discussed in the Company's Annual Report on Form 20-F
and the Company's other filings with the U.S. Securities and Exchange
Commission.
</P>
<P>
</P>
<P>CONTACT: Dan Suesskind |              Chief Financial Officer | Teva Pharmaceutical Industries, Ltd | 011/972-2-5892-811 | or | Bill Fletcher | President and CEO | Teva North America | 215-591-3000 | or | Dorit Meltzer | Director, Investor Relations | Teva Pharmaceutical Industries Ltd. | 011/972-3-9267-554</P>

<!-- end full-text -->

		<FORM METHOD="POST" ACTION="/servlet/EmailOrFax">
<INPUT TYPE="hidden" NAME="story" VALUE="b0828134.602">
<INPUT TYPE="hidden" NAME="level1" VALUE="">
<INPUT TYPE="hidden" NAME="level2" VALUE="">
<INPUT TYPE="hidden" NAME="level3" VALUE="536">
<INPUT TYPE="hidden" NAME="date" VALUE="20000829">
<P>

<P>
<b>Would you like to email or fax this story<br>to a friend?</b></font><br><br></td>
	</tr>
	<tr>
		<td>&nbsp;&nbsp;&nbsp;&nbsp;
<!-- Buttons for Email and Fax a Friend -->

<input type="Hidden" NAME="theButton"><A HREF=JavaScript:userButton("Email_frames")><img src="/images/buttons/email_story_to_a_friend_b.gif" border="0"></A>&nbsp;<A HREF=JavaScript:userButton("Fax_frames")><img src="/images/buttons/fax_story_to_a_friend_b.gif" border="0"></A><br>
	</td>
</tr>
</table></TD>
	<!-- right hand column...125x125 ad, related stories, quicksearch, etc-->
	<TD ALIGN="right" VALIGN="top">
		<TABLE BGCOLOR="#FBEFD1" WIDTH="140" CELLPADDING="8" CELLSPACING="0" BORDER="0">
			<TR><TD BGCOLOR="#345B8A" HEIGHT="20"><FONT FACE="Verdana, Arial, Helvetica, sans-serif" COLOR="#FFFFFF" SIZE="-1"><B>More Articles</B></FONT></TD></TR>
<TR><TD><FONT FACE="Verdana, Arial, Helvetica, sans-serif" SIZE="-1"><A HREF="/frames/story.shtml?story=p0828144.200&date=20000829&level3=536">Schein Pharmaceutical Announces Merger with Wat...</A></FONT></TD></TR>

			
			<TR><TD>
				<!-- Begin DoubleClick ad head --><NOLAYER><IFRAME SRC="http://ad.doubleclick.net/adi/np.newspage.com/Generic+Drugs;depid=536;!category=np_comp;u=b0828134_602;sz=125x125;ord=967546722594?" name="tile" frameborder=0 marginheight=0 marginwidth=0 width=125 height=125 scrolling=no><A HREF="http://ad.doubleclick.net/jump/np.newspage.com/Generic+Drugs;depid=536;!category=np_comp;u=b0828134_602;sz=125x125;ord=967546722594?" target="_top"><IMG BORDER="0" SRC="http://ad.doubleclick.net/ad/np.newspage.com/Generic+Drugs;depid=536;!category=np_comp;u=b0828134_602;sz=125x125;ord=967546722594?"></A></IFRAME></NOLAYER><ILAYER ID=tile VISIBILITY=HIDE HEIGHT=125 WIDTH=125></ILAYER><!-- End DoubleClick ad head -->

			</TD></TR>
			
			<TR><TD BGCOLOR="#345B8A" HEIGHT="20"><FONT FACE="Verdana, Arial, Helvetica, sans-serif" COLOR="#FFFFFF" SIZE="-1"><B>Article Found In</B></FONT></TD></TR>
<TR><TD><FONT FACE="Verdana, Arial, Helvetica, sans-serif" SIZE="-1"><A HREF="/frames/topic.shtml?topic=357&date=20000829">Pharmaceutical Manufacturing</A></FONT></TD></TR>
<TR><TD><FONT FACE="Verdana, Arial, Helvetica, sans-serif" SIZE="-1"><A HREF="/frames/topic.shtml?topic=536&date=20000829">Generic Drugs</A></FONT></TD></TR>
<TR><TD><FONT FACE="Verdana, Arial, Helvetica, sans-serif" SIZE="-1"><A HREF="/frames/topic.shtml?topic=28457&date=20000829">Compensation</A></FONT></TD></TR>
 
			<TR>
      		<TD BGCOLOR="#345B8A" HEIGHT="20"><FONT FACE="verdana, arial, helvetica, san-serif" COLOR="#ffffff" SIZE="-1"><B>Quick Search</B></FONT></TD>
      		</TR>
      		<TR>
      		<TD ><FORM action="http://pf.individual.com/news_search.asp" METHOD=GET>
				<INPUT type="hidden" name="action" value="go">
				<INPUT type="hidden" name="start" value="1">
				<INPUT TYPE="TEXT" SIZE="13" VALUE="" NAME="text">
				<INPUT TYPE="Image" NAME="NewSearchSubmitBtn" SRC="/images/buttons/go_b.gif" alt="Submit" BORDER="0" WIDTH="22" HEIGHT="14" VSPACE="0" HSPACE="0">
				</FORM></TD>
      		</TR>
		</TABLE>
	</td>
	</tr>
	<tr><td><br><IMG SRC="/images/logos/73x29.gif" WIDTH="73" HEIGHT="29"><FONT FACE="Verdana, Arial, Helvetica, sans-serif" SIZE="-2">&nbsp;&nbsp;<A HREF="/terms.shtml" TARGET="CONTENT"><B>Copyright &copy; 2000</B></A>, <A HREF="/about.shtml" TARGET="_top"><B>Individual.com, Inc.</A></B><font size="-5"><sup><font color="#0000CC">TM</font></sup></font>
</td></tr>
	</TABLE>
</td>
</tr>
</table>

	
	<!-- Begin DoubleClick ad foot --><LAYER SRC="http://ad.doubleclick.net/adl/np.newspage.com/Generic+Drugs;depid=536;!category=np_comp;u=b0828134_602;sz=125x125;ord=967546722608?" visibility=hide onload="moveToAbsolute(tile.pageX, tile.pageY); clip.height=125; clip.width=125; visibility='show';"></LAYER><!-- End DoubleClick ad foot -->


	<!-- Begin DoubleClick ad foot --><LAYER SRC="http://ad.doubleclick.net/adl/np.newspage.com/Generic+Drugs;depid=536;!category=np_comp;u=b0828134_602;sz=468x60;ord=967546722610?" visibility=hide onload="moveToAbsolute(banner.pageX, banner.pageY); clip.height=80; clip.width=468; visibility='show';"></LAYER><!-- End DoubleClick ad foot -->


</body>
</html>
